Procalcitonin albumin ratio

Abstract

Because procalcitonin has been recommended as a bacterial infection marker, this study was conducted to investigate the utility of serum PCT as an early marker to decide on intervention for urinary tract infection. We did a one-year retrospective analysis with 200 individuals who had febrile urinary tract infections. The independent risk variables for distinguishing urosepsis from febrile urinary tract infection were identified using univariate and multivariate logistic analysis. To examine the prediction accuracy of the procalcitonin/albumin ratio, a receiver operating characteristic (ROC) curve analysis was performed. The procalcitonin/albumin ratios in the urosepsis group were greater than those in the febrile urinary tract infection group were 84.62 percent and 96.00 percent, respectively. Furthermore, in the subset of 65 patients with urosepsis, the procalcitonin/albumin ratio in the uroseptic shock group was higher than in the non-urosepsis group. Our findings show that the procalcitonin/albumin ratio can distinguish between urosepsis and febrile urinary tract infection early in the diagnostic process. Furthermore, patients with urosepsis who had greater procalcitonin/albumin ratios were more likely to develop uroseptic shock. Our findings show that the procalcitonin/albumin ratio can be employed in clinical practise as a quick and low-cost biomarker.